HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uday Puligadda Selected Research

Hypertrophy

5/2010Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Uday Puligadda Research Topics

Disease

1Cardiomegaly (Heart Hypertrophy)
06/2010
1Heart Failure
06/2010
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
06/2010
1Myocardial Infarction
05/2010
1Hypoxia (Hypoxemia)
05/2010
1Fibrosis (Cirrhosis)
05/2010
1Hypertrophy
05/2010

Drug/Important Bio-Agent (IBA)

2human VEGFB proteinIBA
06/2010 - 05/2010
2Vascular Endothelial Growth Factor BIBA
06/2010 - 05/2010
1Caspase 9IBA
06/2010
1Complementary DNA (cDNA)IBA
06/2010
1Green Fluorescent ProteinsIBA
06/2010
1Neuropilin-1IBA
05/2010
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
05/2010
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
05/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2010
1LigandsIBA
05/2010